SP

Sourabh Pareek

Active Director Designated Partner DIN 09279917
DIN 09279917 First appointment Aug 2021 Primary industry Electrnoics
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Sourabh Pareek

Data last updated:

Sourabh Pareek is a Designated Partner at Genomease Labs Llp (since 2021). The company operates in Electrnoics.

DIN 09279917
Primary Designation Designated Partner
Industry Electrnoics
First Appointment 13 Aug 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner13 Aug 20212021Active

Board colleagues of Sourabh Pareek

NameDINCompanyDesignation
Satya Prakash Pareek09279916Genomease Labs LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Genomease Labs Llp
Premium access

Shareholding and investment profile for Sourabh Pareek

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sourabh Pareek

Sourabh Pareek currently holds 1 directorship: Genomease Labs Llp (Designated Partner, since 13 Aug 2021).

Sourabh Pareek was first appointed on 13 Aug 2021 as Designated Partner at Genomease Labs Llp.

The current boards of Sourabh Pareek's companies include Satya Prakash Pareek (Genomease Labs Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available